Plasma N terminal pro-brain natriuretic peptide levels and its determinants in a multi-ethnic population

Journal of Human Hypertension

Volumn 21, Issue 8, 2007, Pages 647-653

  Abdulle, A M ^a   Nagelkerke, N J D ^a   Adem, A ^a   Abouchacra, S ^b   Pathan, J Y ^a   Al Rukhaimi, M ^c   Suleiman, M N ^c   Mathew, M C ^d   Nicholls, M G ^e   Obineche, E N ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b TAWAM HOSPITAL   (United Arab Emirates)

^c DUBAI HOSPITAL   (United Arab Emirates)

^d Al Qassimi Hospital   (United Arab Emirates)

^e CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE; GLUCOSE; INSULIN; NITROGEN; UREA;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ETHNIC DIFFERENCE; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SOUTHEAST ASIA; SYSTOLIC BLOOD PRESSURE; UNITED ARAB EMIRATES; UREA NITROGEN BLOOD LEVEL;

ADULT; EXERCISE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; UNITED ARAB EMIRATES;

EID: 34547413990     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002210     Document Type: Article

References (35)

1. Davis M, Espiner E, Richards G, Billings J, Town I, Neill A et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 1994; 343: 440-444.
2. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167.
3. Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004; 350: 647-654.
4. Lainchbury JG, Campbell E, Frampton CM, Yandle TG, Nicholls MG, Richards AM. Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 2003; 42: 728-735.
5. Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA, Turner JG et al. Plasma N-terminal probrain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998; 97: 1921-1929.
6. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014-1021.
7. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355 1126-1130.
8. Sagnella GA, Markandu ND, Shore AC, MacGregor GA. Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet 1986; 1: 179-181.
9. Takeda T, Kohno M. Brain natriuretic peptide in hypertension. Hypertens Res 1995; 18: 259-266.
10. Nilsson P, Lindholm L, Schersten B, Horn R, Melander A, Hesch RD. Atrial natriuretic peptide and blood pressure in a geographically defined population. Lancet 1987; 2: 883-885.
11. Abdulle AM, Nagelkerke NJ, Abouchacra S, Pathan JY, Adem A, Obineche EN. Under-treatment and under diagnosis of hypertension: A serious problem in the United Arab Emirates. BMC Cardiovasc Disord 2006; 6: 24.
12. Belluardo P, Cataliotti A, Bonaiuto L, Giuffre E, Maugeri E, Noto P et al. Lack of activation of the molecular forms of the BNP system in human grade 1 hypertension and relationship to cardiac hypertrophy. Am J Physiol Heart Circ Physiol 2006; 291: 1529-1535.
13. Uusimaa P, Tokola H, Ylitalo A, Vuolteenaho O, Ruskoaho H, Risteli J et al. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension. Int J Cardiol 2004; 97: 251-256.
14. Conen D, Zeller A, Pfisterer M, Martina B. Usefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension. Am J Cardiol 2006; 97: 249-252.
15. Yamamoto K, Burnett Jr JC, Jougasaki M, Nishimura RA, Bailey KR, Saito Y et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28: 988-994.
16. Struthers AD, Davies J. B-type natriuretic peptide: A simple new test to identify coronary artery disease? QJM 2005; 98: 765-769.
17. Abdullah SM, Khera A, Das SR, Stanek HG, Canham RM, Chung AK et al. Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of N-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (The Dallas Heart Study). Am J Cardiol 2005; 96: 1284-1289.
18. Rana BS, Davies JI, Band MM, Pringle SD, Morris A, Struthers AD. B-type natriuretic peptide can detect silent myocardial ischaemia in asymptomatic type 2 diabetes. Heart 2006; 92: 916-920.
19. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett Jr JC. Plasma brain natriuretic peptide concentration: Impact of age and gender. J Am Coll Cardiol 2002; 40: 976-982.
20. Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PW et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 2002; 90: 254-258.
21. Raymond I, Groenning BA, Hildebrandt PR, Nilsson JC, Baumann M, Trawinski J et al. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003; 89: 745-751.
22. Clerico A, Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: A review. Clin Chem 2004; 50: 33-50.
23. Mottram PM, Haluska BA, Marwick TH. Response of B-type natriuretic peptide to exercise in hypertensive patients with suspected diastolic heart failure: Correlation with cardiac function, hemodynamics, and work-load. Am Heart J 2004; 148: 365-370.
24. Neumayr G, Pfister R, Mitterbauer G, Eibl G, Hoertnagl H. Effect of competitive marathon cycling on plasma N-terminal pro-brain natriuretic peptide and cardiac troponin T in healthy recreational cyclists. Am J Cardiol 2005; 96: 732-735.
25. Meredith IT, Jennings GL, Esler MD, Dewar EM, Bruce AM, Fazio VA et al. Time-course of the antihypertensive and autonomic effects of regular endurance exercise in human subjects. J Hypertens 1990; 8: 859-866.
26. Luchner A, Schunkert H. Interactions between the sympathetic nervous system and the cardiac natriuretic peptide system. Cardiovasc Res 2004; 63: 443-449.
27. Passino C, Severino S, Poletti R, Piepoli MF, Mammini C, Clerico A et al. Aerobic exercise decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. J Am Coll Cardiol 2006; 47: 1835-1839.
28. Amine EK, Samy M. Obesity among female medical students in the United Arab Emirates. J R Soc Health 1996; 116: 91-96.
29. Henry CJK, Lightowler HJ, Al-Hourani H. Physical activity and levels of inactivity in adolescent females ages 11-16 years in the United Arab Emirates. Am J Human Biol 2004; 16: 346-353.
30. Sabri S, Bener A, Eapen V, Abu Zeid MS, Al-Mazrouei AM, Singh J. Some risk factors for hypertension in the United Arab Emirates. East Mediterr Health J 2004; 10: 610-619.
31. Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM et al. Impact of body mass and body composition on circulating levels of natriuretic peptides. Results from the Dallas Heart Study. Circulation 2005; 112: 2163-2168.
32. Maisel AS, Clopton P, Krishnaswamy P, Nowak RM, McCord J, Hollander JE et al. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. Am Heart J 2004; 147: 1078-1084.
33. Kohno M, Minami M, Kano H, Yasunari K, Maeda K, Hanehira T et al. Effect of angiotensin-converting enzyme inhibitor on left ventricular parameters and circulating brain natriuretic peptide in elderly hypertensives with left ventricular hypertrophy. Metabolism 2000; 49: 1356-1360.
34. Dahlof B, Zanchetti A, Diez J, Nicholls MG, Yu CM, Barrios V et al. For the REGAAL Study Investigators. Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy. J Hypertens 2002; 20: 1855-1864.
35. Deary AJ, Schumann AL, Murfet H, Haydock S, Foo RS, Brown MJ. Influence of drugs and gender on the arterial pulse wave and natriuretic peptide secretion in untreated patients with essential hypertension. Clin Sci 2002; 103: 493-499.